amifostine anhydrous has been researched along with mitomycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Anđelković, B; Dajić-Stevanović, Z; Gođevac, D; Novaković, M; Petrović, M; Stanković, J; Stanković, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cathcart, KN; Crawford, JM; Flatow, J; Holden, SA; Lin, Y; Luchette, CA; Teicher, BA | 1 |
| Baker, L; Gullo, JJ; Leming, PD; Lokich, JJ; LoRusso, P; McCulloch, W; Poplin, EA; Schein, P; Schulz, JJ; Veach, SR | 1 |
| Awada, A; Geurs, F; Habboubi, N; Kerger, J; Kusenda, Z; Piccart, MJ; Van Vreckem, A | 1 |
| Camelo, RM; Kehdy, FS; Lopes, MT; Salas, CE | 1 |
| Mandic, BM; Savic, VM; Simic, MR; Stankovic, M; Tesevic, VV | 1 |
| Bouhadjari, N; Calabrese, D; Gabato, W; Keita, H; Msika, S | 1 |
| Chaumais, MC; Humbert, M; Montani, D; Seferian, A | 1 |
1 review(s) available for amifostine anhydrous and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for amifostine anhydrous and mitomycin
| Article | Year |
|---|---|
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.
Topics: Adult; Aged; Amifostine; Bone Marrow Diseases; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Mitomycin | 1994 |
Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Topics: Adult; Aged; Amifostine; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Feasibility Studies; Female; Hematologic Diseases; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Neoplasm Metastasis; Pilot Projects; Prospective Studies; Radiation-Protective Agents; Treatment Outcome; Vinblastine | 1997 |
7 other study(ies) available for amifostine anhydrous and mitomycin
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Phenolic Compounds from Atriplex littoralis and Their Radiation-Mitigating Activity.
Topics: Atriplex; Coumarins; Fruit; Humans; Malaysia; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Plant Bark; Plant Leaves | 2015 |
Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide.
Topics: Amifostine; Animals; Carmustine; Cell Line; Cyclophosphamide; Drug Interactions; Fibrosarcoma; Glutathione; Liver; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Monocrotaline; Pyrrolizidine Alkaloids | 1988 |
Amifostine protection against mitomycin-induced chromosomal breakage in fanconi anaemia lymphocytes.
Topics: Adolescent; Adult; Amifostine; Blood Cells; Case-Control Studies; Child; Chromosome Breakage; Fanconi Anemia; Female; Humans; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mitomycin; Reactive Oxygen Species | 2008 |
Synthesis of novel tetrahydrobenzazepine derivatives and their cytoprotective effect on human lymphocytes.
Topics: Alkylating Agents; Amifostine; Antioxidants; Benzazepines; Cells, Cultured; Cytochalasin B; Cytoprotection; Dose-Response Relationship, Drug; Drug Design; Humans; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Molecular Structure; Oxidative Stress; Radiation-Protective Agents; Structure-Activity Relationship | 2015 |
Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Creatinine; Cytoreduction Surgical Procedures; Female; Free Radical Scavengers; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Ovarian Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Retrospective Studies | 2016 |
[Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Anus Neoplasms; Humans; Hypertension, Pulmonary; Mitomycin; Pulmonary Veno-Occlusive Disease; Radiation-Protective Agents; Rats | 2017 |